38 results on '"Longinetti, Elisa"'
Search Results
2. Comparing the Safety and Effectiveness of Different Medicines to Treat Multiple Sclerosis – The COMBAT-MS Study
3. Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort
4. Trajectories of self-reported fatigue following initiation of multiple sclerosis disease-modifying therapy
5. Comparing the Safety of Medicines to Treat MS during the COVID-19 Pandemic
6. Sustained Low Relapse Rate With Highly Variable B-Cell Repopulation Dynamics With Extended Rituximab Dosing Intervals in Multiple Sclerosis
7. Heart rate, intelligence in adolescence, and Parkinson’s disease later in life
8. History of violence/maltreatment and psychogenic non-epileptic seizures
9. Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis diseasemodulating therapy.
10. Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy
11. Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy
12. Utilization of social media and web forums by HIV patients - A cross-sectional study on adherence and reported anxiety level
13. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature
14. Correlates of mobile phone use in HIV care: Results from a cross-sectional study in South Africa
15. Sustained Low Relapse Rate With Highly Variable B-Cell Repopulation Dynamics With Extended Rituximab Dosing Intervals in Multiple Sclerosis
16. COVID‐19 clinical outcomes and DMT of MS patients and population‐based controls
17. Geographical clusters of amyotrophic lateral sclerosis and the Bradford Hill criteria
18. Mortality among family members of patients with amyotrophic lateral sclerosis – a Swedish register-based study
19. Risk of depression in multiple sclerosis across disease-modifying therapies
20. ALS patients with concurrent neuroinflammatory disorders; a nationwide clinical records study
21. sj-docx-5-msj-10.1177_13524585211031128 – Supplemental material for Risk of depression in multiple sclerosis across disease-modifying therapies
22. sj-docx-2-msj-10.1177_13524585211031128 – Supplemental material for Risk of depression in multiple sclerosis across disease-modifying therapies
23. sj-docx-3-msj-10.1177_13524585211031128 – Supplemental material for Risk of depression in multiple sclerosis across disease-modifying therapies
24. sj-docx-1-msj-10.1177_13524585211031128 – Supplemental material for Risk of depression in multiple sclerosis across disease-modifying therapies
25. sj-docx-4-msj-10.1177_13524585211031128 – Supplemental material for Risk of depression in multiple sclerosis across disease-modifying therapies
26. Mortality among family members of patients with amyotrophic lateral sclerosis – a Swedish register-based study
27. Geographical clusters of amyotrophic lateral sclerosis and the Bradford Hill criteria.
28. Mortality among family members of patients with amyotrophic lateral sclerosis – a Swedish register-based study.
29. ALS patients with concurrent neuroinflammatory disorders; a nationwide clinical records study.
30. Risk of depression in multiple sclerosis across disease-modifying therapies.
31. Associations between autoimmune diseases and amyotrophic lateral sclerosis: a register-based study
32. Associations between autoimmune diseases and amyotrophic lateral sclerosis: a register-based study
33. Associations between autoimmune diseases and amyotrophic lateral sclerosis: a register-based study.
34. The Swedish motor neuron disease quality registry
35. Neurodegenerative and psychiatric diseases among families with amyotrophic lateral sclerosis
36. Gender Perspective of Risk Factors Associated with Disclosure of HIV Status, a Cross-Sectional Study in Soweto, South Africa
37. Predictors of Patient-Reported Fatigue Symptom Severity in a Nationwide Multiple Sclerosis Cohort
38. Symptomatic drug therapy impact on Amyotrophic Lateral Sclerosis survival
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.